Skip to main content

Advertisement

Log in

Human parvovirus B19-associated disease in bone marrow transplantation

  • Brief Report
  • Published:
Infection Aims and scope Submit manuscript

Summary

Human parvovirus B19 can persist in immunocompromised patients and may produce severe clinical illness. In this retrospective study the incidence of B19-associated infections in bone marrow transplant patients was investigated. During 1 year 60 patients received bone marrow grafts (eight autografts and 52 allogeneic transplantations). In case of early onset, atypical or steroid-resistant erythrodermia the patients' blood and/or tissue specimens were screened for B19 infection by polymerase chain reaction (PCR). Additionally, specimens of patients with severe organ failure were tested. A total of 64 PCRs was performed in 27 patients. Seven patients with erythrodermia and one with vulvovaginitis proved to be PCR positive. In patients with organ failure B19 DNA was detected in the myocardium and liver. The incidence of B19 infections in this cohort was 15% and the B19-associated mortality rate 7%. In conclusion, parvovirus B19-associated infections may be more common in immunocompromised patients than previously anticipated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Berns, K. I.: Parvoviridae and their replication. In:Fields, B. N., Knipe, D. M. (eds.): Virology, 2nd ed. Raven Press, New York 1990, pp. 1743–1760.

    Google Scholar 

  2. Kurtzman, G. J., Cascon, P., Caras, M., Cohen, B., Young, N. S.: B19 parvovirus replicates in circulating cells of acutely infected patients. Blood 71 (1988) 1448–1454.

    PubMed  CAS  Google Scholar 

  3. Török, T.: Parvovirus B19 and human disease. Adv. Intern. Med. 37 (1992) 431–455.

    PubMed  Google Scholar 

  4. Kurtzman, G. J., Frickhofen, N., Kimball, J., Jenkins, D. W., Nienhuis, A. W., Young, N. S.: Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med. 321 (1989) 519–525.

    Article  PubMed  CAS  Google Scholar 

  5. Schwarz, T. F., Roggendorf, M., Deinhardt, F.: Human parvovirus B19: ELISA and immunoblot assays. J. Virol. Methods 20 (1988) 155–168.

    Article  PubMed  CAS  Google Scholar 

  6. Schwarz, T. F., Jäger, G., Holzgreve, W., Roggendorf, M.: Diagnosis of human parvovirus B19 infections by polymerase chain reaction. Scand. J. Infect. Dis. 24 (1992) 691–696.

    PubMed  CAS  Google Scholar 

  7. Frickhofen, N., Arnold, R., Hertenstein, B., Wiesneth, M., Young, N. S.: Parvovirus B19 infection and bone marrow transplantation. Ann. Hematol. 64 (1992) A121-A124.

    Article  PubMed  Google Scholar 

  8. Soderlund, M., Ruutu, P., Ruutu, T., Asikainen, K., Franssila, R., Hedman, K.: Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology. Scand. J. Infect. Dis. 29 (1997) 129–135.

    Article  PubMed  CAS  Google Scholar 

  9. Chia, J. K. S., Jackson, B.: Myopericarditis due to parvovirus B19 in an adult. Clin. Infect. Dis. 23 (1996) 200–201.

    PubMed  CAS  Google Scholar 

  10. Yoto, Y., Kudoh, T., Haseyama, K., Suzuki, N., Chiba, S.: Human parvovirus B19 infection associated with acute hepatitis. Lancet 347 (1996) 868–869.

    Article  PubMed  CAS  Google Scholar 

  11. Brown, K. E., Anderson, S. M., Young, N. S.: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 262 (1993) 114–117.

    Article  PubMed  CAS  Google Scholar 

  12. Nikkari, S., Lappalainen, H., Saario, R., Lammintausta, K., Kotilainen, P.: Detection of parvovirus B19 in skin biopsy, serum, and bone marrow of a patient with fever, rash, and polyarthritis followed by pneumonia, pericardial effusion, and hepatitis. Eur. J. Microbiol. Infect. Dis. 15 (1996) 954–957.

    Article  CAS  Google Scholar 

  13. Lefrère, J.-J., Mariotti, M. Thauvin, M.: B19 parvovirus DNA in solvent/detergen-treated anti-haemophilia concentrates. Lancet 342 (1994) 211–212.

    Article  Google Scholar 

  14. Saldanha, J., Minor, P.: Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture. Brit. J. Haematol. 93 (1996) 714–719.

    Article  CAS  Google Scholar 

  15. Kurtzman, G. J., Cohen, B., Meyers, P., Amunullah, A., Young, N. S.: Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukaemia. Lancet 0 (1988) 1159–1162.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schleuning, M., Jäger, G., Holler, E. et al. Human parvovirus B19-associated disease in bone marrow transplantation. Infection 27, 114–117 (1999). https://doi.org/10.1007/BF02560509

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02560509

Keywords

Navigation